ORIC Pharmaceuticals, Inc. Stock Börse Stuttgart
Equities
4TZ
US68622P1093
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8 EUR | -2.44% | -4.19% | -1.84% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 595M 551M 819M |
---|---|---|---|---|---|
Net income 2024 * | -114M -106M -157M | Net income 2025 * | -138M -128M -190M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.13
x | P/E ratio 2025 * |
-4.57
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.45% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 week | -4.19% | ||
Current month | -4.19% | ||
1 month | -6.98% | ||
3 months | -44.83% | ||
6 months | -2.44% | ||
Current year | -1.84% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Date | Price | Change |
---|---|---|
24-06-07 | 8 | -2.44% |
24-06-06 | 8.2 | +4.46% |
24-06-05 | 7.85 | -1.26% |
24-06-04 | 7.95 | -3.05% |
24-06-03 | 8.2 | -1.80% |
Delayed Quote Börse Stuttgart, June 07, 2024 at 09:58 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ORIC Stock
- 4TZ Stock